{"schema_version":"secwatch.filing_event.v1","accession":"0001079973-25-000165","form_type":"8-K","ticker":"PDEX","cik":"0000788920","company_name":"PRO DEX INC","filed_at":"2025-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.353148+00:00","generated_at":"2026-05-27T06:10:46.634705+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Pro-Dex Q2 net sales up 33% to $16.8M; EPS $0.61 vs $0.14","bullets":["Q2 net sales $16.8M (+33% YoY) driven by $3.1M shipment of next-gen orthopedic handpiece for largest customer.","Net income $2.0M ($0.61 diluted) vs $0.5M ($0.14) prior year; gross margin 30% vs 22%.","Six-month net income $4.5M ($1.33 diluted) vs net loss $115K; includes $510K unrealized gains on investments.","Operating income rose 247% to $2.7M on higher sales and improved margins.","CEO expects Q3 and Q4 revenue growth from continued production shipments of next-generation handpiece."],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-25-000165","json":"https://secwatch.observer/filing/0001079973-25-000165.json","markdown":"https://secwatch.observer/filing/0001079973-25-000165.md","text":"https://secwatch.observer/filing/0001079973-25-000165.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/788920/000107997325000165/0001079973-25-000165-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/788920/000107997325000165/pdex_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T06:10:46.634705+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}